Literature DB >> 4067839

The kinetics of chlorite and chlorate in rats.

M S Abdel-Rahman, D Couri, R J Bull.   

Abstract

Chlorine dioxide (ClO2) is under consideration as an alternative to chlorination as a disinfectant for public water supplies. The primary products resulting from ClO2 disinfection of surface waters are chlorite (ClO2-) and chlorates (ClO3-). The kinetics of 36ClO2- and 36ClO3- was studied in rats. Radioactivity was rapidly absorbed from the gastrointestinal tract following the administration of (0.17 microCi) 36ClO2- or (0.85 microCi) 36ClO3- orally; and 36Cl in plasma reached a peak at 2 hr and 1 hr, respectively. After 72 hr, radioactivity was highest in whole blood, followed by packed cells, plasma, stomach, testes, skin, lung, kidney, duodenum, carcass, spleen, ileum, brain, bone marrow and liver in 36ClO2- treatment. 36Cl excretion was greatest at 24 hr after the administration of 36ClO3-, but in the 36ClO2-, the excretion most likely represented saturation of the biotransformation and excretion pathways. About 40% of the total initial dose was excreted at 72 hr in the urine and feces in both treatments. No 36Cl was detected in expired air throughout the 72 hr studied.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067839

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  2 in total

1.  Cytoprotective effect of taurine against sodium chlorate-induced oxidative damage in human red blood cells: an ex vivo study.

Authors:  Shaikh Nisar Ali; Amin Arif; Fariheen Aisha Ansari; Riaz Mahmood
Journal:  Amino Acids       Date:  2022-01-06       Impact factor: 3.520

2.  Effect of drinking-water administration of experimental chlorate ion preparations on Salmonella enterica serovar Typhimurium colonization in weaned and finished pigs.

Authors:  R C Anderson; M E Hume; K J Genovese; T R Callaway; Y S Jung; T S Edrington; T L Poole; R B Harvey; K M Bischoff; D J Nisbet
Journal:  Vet Res Commun       Date:  2004-04       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.